Emerging Role of Sodium-Glucose Cotransporter-2 Inhibitors in Aortic Stenosis
{{output}}
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have emerged as a key drug class in the management of heart failure, expanding far beyond their original use in type 2 diabetes mellitus. Aortic stenosis (AS), the most common valvular heart disease in the agin... ...
